2008 Symposium Information

Topic: Building a Framework for Biomarker Application
Location: Bethesda North Marriott Hotel & Conference Center, Rockville, Maryland
Date: October 17-19, 2007

Objectives:

• Examine surrogate endpoints and controversies regarding their use in cardiovascular and diabetes drug approvals
• Review the latest biomarker and imaging technology data from recently completed clinical trials
• Identify best practices for biomarker assessment and validation
• Build a framework for biomarker application in research, development and clinical practice

2008 Agenda

2008 Faculty

The 2008 Cardiovascular Biomarkers and Surrogate Endpoints Symposium Planning Committee would like to thank the following corporate sponsors for their generosity in providing financial support for this program:

Gold Sponsors
Merck Research Laboratories
General Electric Healthcare
AstraZeneca
F. Hoffmann-La Roche
ClinXus
Silver Sponsors
Pfizer Canada
CSL, Ltd
Pfizer
Bronze Sponsors
Cortria Corporation
Via Pharmaceuticals
AtCor Medical
deCode Genetics
ZORA Biosciences
Novartis
LipoScience
Servier Canada Inc.
Additional Sponsors
Wyeth
Boehringer-Ingelheim

Past Symposia:

2007 CV Biomarkers Symposium, Bethesda, MD

2006 CV Biomarkers Symposium, Bethesda, MD

2005 CV Biomarkers Symposium, Bethesda, MD

2004 CV Biomarkers Symposium, Bethesda, MD

2003 CV Biomarkers Symposium, Bethesda, MD